Hyperuricaemia

Hyperuricaemia means the blood carries more uric acid than the kidneys can clear. Most people have no symptoms for years, but when urate crystals start depositing in joints or the kidneys, the result can be an acute gout attack or kidney stones. Rates are notably high across East and Southeast Asia, dietary patterns rich in red meat, shellfish, organ meats, and sweetened drinks, combined with a genetic tendency toward reduced uric acid excretion, make gout one of the most common inflammatory joint conditions in countries such as Taiwan, South Korea, and Malaysia.

Medicines used to treat Hyperuricaemia

Zyloprim

Allopurinol

100 · 300mg

Formulated to target gout to alleviate elevated uric acid.

From $0.37 / tablet View

Uloric

Febuxostat

40 · 80mg

Formulated to alleviate chronic high uric acid and intended to support patients with gout.

From $0.85 / tablet View

Benemid

Probenecid

500mg

This medicine is utilized to manage chronic gout intended to support uric acid excretion and mitigate recurrence of symptoms.

From $0.76 / tablet View

What drives uric acid too high

Uric acid is the end product of purine breakdown. When the body produces too much or the kidneys excrete too little, levels climb. Common drivers include a diet heavy in high-purine foods (organ meats, anchovies, beer), dehydration, certain blood pressure medicines, and underlying conditions such as chronic kidney disease or metabolic syndrome. A single acute gout flare, sudden, severe pain and swelling, most often in the big toe, is often the first sign that levels have been elevated for some time.

Bringing levels down with medicine

The goal of treatment is to reduce uric acid steadily to below 360 µmol/L (or lower if tophi are present). Allopurinol is the most widely used first-line agent; it works by blocking xanthine oxidase, the enzyme that produces uric acid. Febuxostat is a more selective xanthine oxidase inhibitor used when allopurinol is not well tolerated. Probenecid takes a different route, it increases renal excretion of urate rather than reducing production, making it useful in under-excreters with adequate kidney function. Any of these may briefly raise the risk of a gout flare when first started, so they are usually introduced at a low dose and increased gradually. Flare management sits in the broader pain management toolkit.

Staying well hydrated and moderating alcohol and purine-rich foods supports whichever medicine is used, but dietary change alone rarely brings levels into the target range once hyperuricaemia is established.